Drug interactions between Aleve and Vicks NyQuil Severe Cold & Flu
|Vicks NyQuil Severe Cold & Flu (acetaminophen/dextromethorphan/doxylamine/phenylephrine)|
Interactions between your drugs
There were no interactions found in our database between Aleve and Vicks NyQuil Severe Cold & Flu - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Aleve is in the drug class Nonsteroidal anti-inflammatory drugs.
- Aleve is used to treat the following conditions:
- Ankylosing Spondylitis
- Aseptic Necrosis
- Back Pain
- Chronic Myofascial Pain
- Diffuse Idiopathic Skeletal Hyperostosis
- Frozen Shoulder
- Gout, Acute
- Juvenile Rheumatoid Arthritis
- Muscle Pain
- Neck Pain
- Period Pain
- Rheumatoid Arthritis
Vicks NyQuil Severe Cold & Flu
- Vicks NyQuil Severe Cold & Flu is a member of the drug class upper respiratory combinations.
- Vicks NyQuil Severe Cold & Flu is used to treat the following conditions:
Drug and food interactions
Applies to: Vicks NyQuil Severe Cold & Flu (acetaminophen / dextromethorphan / doxylamine / phenylephrine)
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
- Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7
- "Product Information. Fycompa (perampanel)." Eisai Inc, Teaneck, NJ.
- "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc, Rockville, MD.
- Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.